Dr. Tom Tadros an Electrophysiologist from Harvard Medical School - The Brigham & Women’s Hospital discusses the landmark EAST-AFNET 4 study which highlights the importance of early-rhythm control therapy in patients with atrial fibrillation.
Early Rhythm Control Therapy - the EAST-AFNET 4 Trial
Previous
Previous
Heart Failure and Atrial Fibrillation
Next
Next

